Related Experiment Video
Updated: Mar 25, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
Published on: January 30, 2020
Pharmacotherapy Considerations for the Management of Advanced Cardiac Life Support
Craig J Beavers1, Komal A Pandya1
1Department of Pharmacy Practice and Science, University of Kentucky UK Healthcare, Room H-110, 800 Rose Street, Lexington, KY 40536, USA.
Abstract:
Health care providers should be aware of the pharmacotherapy considerations in the American Heart Association's guidelines for advanced cardiac life support (ACLS). Current evidence does not suggest a reduction in mortality with ACLS medications; however, these medications can improve return of spontaneous circulation. Proper agent selection and dosing are imperative to maximize benefit and minimize harm. The latest guideline update included major changes to the ventricular fibrillation/pulseless ventricular tachycardia and pulseless electrical activity/asystole algorithms, which providers should adopt. It is critical that providers be prepared for post-code management. Health care professionals should remain abreast of changing evidence and guidelines.
More Related Videos
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure VI: Adjunct Therapies
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Coronary Artery Disease V: Interprofessional Care
Heart Failure V: Medical Management